These not very encouraging (mildly put) Kyprolis Trial results, further enhances PAB's SM6 importance and Trial which is about to commence any time now.......That is, any time between now and end of the year....
It should be added, PAB's MM Antibodies have an almost Impacable Safety record thus far, something that will be taken STRONGLY INTO CONSIDERATION, If Onyx-Amgen were to take into account (as , I am sure they will...) their Latest "mediocre" safety Trial results.....
Cheers)))
ONXY trial, page-10
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1773666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 10.06am 16/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable